CN Patent

CN102816157B — 作为comt抑制剂的硝基儿茶酚衍生物

Assigned to Bial Portela and Cia SA · Expires 2016-05-18 · 10y expired

What this patent protects

描述了通式I所示的新的化合物，该化合物在治疗一些中枢神经和周围神经系统机能障碍中具有潜在的有价值的药物特性。

USPTO Abstract

描述了通式I所示的新的化合物，该化合物在治疗一些中枢神经和周围神经系统机能障碍中具有潜在的有价值的药物特性。

Drugs covered by this patent

Patent Metadata

Patent number: CN102816157B
Jurisdiction: CN
Classification: —
Expires: 2016-05-18
Drug substance claim: No
Drug product claim: No
Assignee: Bial Portela and Cia SA
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.